ANLBIO

ANLBIO is a researcher and developer of adeno-associated virus-based gene therapy products.

#SimilarOrganizations #People #Financial #Website #More

ANLBIO

Industry:

Genetics Medical Therapeutics

Founded:

2019-01-01

Address:

Seongnam, Kyonggi-do, South Korea

Country:

South Korea

Website Url:

http://www.anlbio.com

Status:

Active

Contact:

+82 031 213 5115

Email Addresses:

[email protected]

Total Funding:

12.5 B KRW

Technology used in webpage:

IPhone / Mobile Compatible Euro Mobile Non Scaleable Content Pound Sterling Japanese Yen UNPKG

Similar Organizations

anlong-bio-logo

Anlong Bio

Anlong Bio focuses on the research and development of nucleic acid drugs, including gene therapy, RNA drugs, and gene editing.

cell-products-of-national-engineering-research-center-logo

Cell Products of National Engineering Research Center

Cell Products of National Engineering Research Center engages in the research and development of cell therapeutic products.

corrgene-logo

CorrGene

CorrGene is a researcher and developer of rare disease cell therapy.

ever-supreme-bio-technology-logo

Ever Supreme Bio Technology

Ever Supreme Bio Technology is engaged in the research and development of cell gene therapies

sibiono-genetech-logo

SiBiono GeneTech

SiBiono is a pioneer in the field of gene therapy industry.

viewgene-logo

ViewGene

ViewGene is a gene therapy company that has developed a proprietary inducible and tissue-specific gene therapy platform.

zenick-lab-logo

Zenick Lab

Zenick Lab provides the discovery of new biomarkers and the development of diagnostic methods based on genetic analysis.

Current Employees Featured

not_available_image

Hong Sung Moon
Hong Sung Moon Founder & Chief Executive Officer @ ANLBIO
Founder & Chief Executive Officer
2019-01-01

Founder

not_available_image

Hong Sung Moon

Investors List

friend-investment-partners_image

Friend Investment Partners

Friend Investment Partners investment in Series A - ANLBIO

bnk-venture-capital-c3fd_image

BNK Venture Capital

BNK Venture Capital investment in Series A - ANLBIO

posco-capital_image

POSCO CAPITAL

POSCO CAPITAL investment in Series A - ANLBIO

hyundai-technology-investment_image

Hyundai Technology Investment

Hyundai Technology Investment investment in Series A - ANLBIO

Official Site Inspections

http://www.anlbio.com

Host Informations
Whois Informations

Loading ...

More informations about "ANLBIO"

GenixCure

제3자배정 신주발행 공고. 2024년 3월 6일 제닉스큐어㈜는 신주발행에 있어서 정관에 정한 바에 따라 긴급한 자금조달을 위하여 제3자배정 방식으로 심본뉴챌린지투자조합에게 다음과 같이 신주 8,663주를 배정하기로 이사회에서 …See details»

ANLBIO - Crunchbase Company Profile & Funding

Organization. ANLBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... ANLBIO closed its last …See details»

ANLBIO - Funding, Financials, Valuation & Investors - Crunchbase

ANLBIO is a researcher and developer of adeno-associated virus-based gene therapy products. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»

ANLBIO - VentureRadar

ANLBio is Developing a platform that can dramatically shorten the time to discover more accurate microRNA targets through artificial intelligence (AI). We develop RNA treatments that can …See details»

ANLBIO - Products, Competitors, Financials, Employees, …

ANLBIO was founded in 2019. Where is ANLBIO's headquarters? ANLBIO's headquarters is located at #901, Ace Gwanggyo Tower 3, 77, Changnyong-daero 256beon-gil, Yeongtong-gu, …See details»

ANLBIO - Contacts, Employees, Board Members, Advisors

Organization. ANLBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. ANLBIO has 1 …See details»

ANLBIO Co., Ltd. South Korea, Suwon | Info-clipper.com

ANLBIO Co., Ltd. is a company registered in South Korea. Info-clipper.com brings you a complete range of reports and documents featuring legal and financial data, facts, analysis and official …See details»

ANLBIO - Company Profile - Tracxn

ANLBIO - Developer of gene therapies for neurological diseases. from 1 investor. ANLBIO has 461 competitors.See details»

GenixCure Company Profile 2024: Valuation, Funding & Investors

GenixCure General Information Description. Developer of gene therapies intended to address the underlying genetic causes of diseases. The company develops adreno-associated virus (AAV) …See details»

ANLBIO - Crunchbase

ANLBIO is a researcher and developer of adeno-associated virus-based gene therapy products.See details»

ANLBIO Stock Price, Funding, Valuation, Revenue & Financial …

Feb 17, 2022 See ANLBIO funding rounds, investors, investments, exits and more. Evaluate their financials based on ANLBIO's post-money valuation and revenue. ANLBIO Stock Price, …See details»

Biovian to support ANLBIO Alzheimer’s gene therapy - BioProcess …

CDMO Biovian Oy says it has the capacity to support viral vector needs through trials and beyond for ANLBIO from its Turku, Finland facilities. BioProcess International is part of the Informa …See details»

ANLBIO signs an agreement with Biovian for process development …

ANLBIO, a biotechnology company developing gene therapies for neurodegenerative diseases, has selected Biovian Oy as a CDMO partner. The agreement covers process ... Biovian is a …See details»

ANLBIO selected Biovian for manufacturing of AAV-based product …

Feb 18, 2022 ANLBIO wants to address this need through the development and commercialization of innovative delivery platforms such as ANL-101. Antti Nieminen, CEO of …See details»

Series A - ANLBIO - 2022-02-17 - Crunchbase Funding Round Profile

Feb 17, 2022 Organization Name . ANLBIO . Announced Date Feb 17, 2022; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . ₩12.5B. Investors. Edit …See details»

ANL바이오, "miRNA 조절 AD 유전자치료제 개발" - 바이오스펙테이터

Jul 16, 2020 한편 anlbio는 '아름다운 노화와 건강한 장수'를 이념으로 2019년 4월 문을 열었다. 비임상 CRO 켐온의 회장이었던 문홍성 대표가 노화와 관련한 투자와 사업화를 추진하던 중 …See details»

One-stop-shop CDMO to support manufacturing of AAV-based …

Mar 8, 2022 The contract development and manufacturing organization (CDMO) is partnering with ANLBIO, a company developing its miRNA-based gene therapy for neurodegenerative …See details»

Hong Sung Moon - Founder & Chief Executive Officer @ ANLBIO ...

Primary Organization . ANLBIO . Location Seongnam, Kyonggi-do, South Korea; Regions Asia-Pacific (APAC) Gender Male; Hong Sung Moon is the Founder & Chief Executive Officer of …See details»

제닉스큐어(주) 2024년 기업정보 | 직원수, 근무환경, 복리후생 등

제닉스큐어(주) 기업소개 - 업력 : 6년차, 기업형태 : 중소기업, 업종 : 의학 및 약학 연구개발업 | 제닉스큐어(주)의 직원수, 연봉, 채용, 근무환경, 복리후생, 재무정보 등이 궁금하시다면, …See details»

ANLBIO - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Organization. ANLBIO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 6. About. ANLBIO is …See details»

America

Europe

Asia

Others

ANLBIO

ANLBIO

Industry:

Founded:

Address:

Country:

Website Url:

Status:

Contact:

Email Addresses:

Total Funding:

Technology used in webpage:

Similar Organizations

Current Employees Featured

Founder

Investors List

Official Site Inspections

More informations about "ANLBIO"

GenixCure

ANLBIO - Crunchbase Company Profile & Funding

ANLBIO - Funding, Financials, Valuation & Investors - Crunchbase

ANLBIO - VentureRadar

ANLBIO - Products, Competitors, Financials, Employees, …

ANLBIO - Contacts, Employees, Board Members, Advisors

ANLBIO Co., Ltd. South Korea, Suwon | Info-clipper.com

ANLBIO - Company Profile - Tracxn

GenixCure Company Profile 2024: Valuation, Funding & Investors

ANLBIO - Crunchbase

ANLBIO Stock Price, Funding, Valuation, Revenue & Financial …

Biovian to support ANLBIO Alzheimer’s gene therapy - BioProcess …

ANLBIO signs an agreement with Biovian for process development …

ANLBIO selected Biovian for manufacturing of AAV-based product …

Series A - ANLBIO - 2022-02-17 - Crunchbase Funding Round Profile

ANL바이오, "miRNA 조절 AD 유전자치료제 개발" - 바이오스펙테이터

One-stop-shop CDMO to support manufacturing of AAV-based …

Hong Sung Moon - Founder & Chief Executive Officer @ ANLBIO ...

제닉스큐어(주) 2024년 기업정보 | 직원수, 근무환경, 복리후생 등

ANLBIO - Tech Stack, Apps, Patents & Trademarks - Crunchbase